A 51-Year-Old Woman with Diffuse Large B-Cell Lymphoma

Gilles Salles, MD, PhD, presents the case of a woman with relapsed/refractory DLBCL who refused stem cell transplant and CAR T-cell therapy, explains the available third-line treatment options, and discusses clinical trial data on a promising combination therapy.